WBA Walgreens Boots Alliance (NASDAQ) $11.98 intraday 11 Mar 2026: most active

WBA stock trades at $11.98 on the NASDAQ in the United States during intraday action on 11 Mar 2026. Volume is the headline: 452,081,061.00 shares have printed, roughly 26.69 times average daily volume. The quote is up 0.06 or 0.50% versus the prior close. We view today’s activity as a liquidity-driven session that highlights both retail interest and institutional rotation into the healthcare retail complex.

WBA stock: Intraday market activity

Walgreens Boots Alliance, Inc. (WBA) is trading on NASDAQ at $11.98 with a 0.50% intraday uptick. Volume is 452,081,061.00 versus an average of 16,940,296.00, giving a relative volume of 26.69. The intraday range is narrow at $11.98 to $11.98, reflecting trades executed at the same print during this pause in price discovery.

WBA stock: Fundamentals and valuation

Walgreens Boots Alliance shows a market cap near $10.37 billion and reported EPS of -7.29, yielding a trailing PE of -1.64. Price to sales is 0.09 and price to book is 1.44, while debt to equity sits at 4.04. Liquidity metrics are thin with a current ratio of 0.60, and free cash flow per share is -0.59, underlining material balance-sheet and cash-flow constraints.

WBA stock: Technical and trading signals

Technically, WBA’s 50-day average is 11.66 and the 200-day is 10.81, placing the stock above long-run support. Key levels are the year high 13.25 and year low 8.08. Momentum indicators show RSI at 100.00 and ADX at 50.00, signalling strong directional activity during heavy volume. Traders should note ATR 0.16 for tight stop sizing.

WBA stock: Meyka AI rates WBA with a score out of 100

Meyka AI rates WBA with a score out of 100: 59.58 (Grade C+, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects $4.08 versus the current $11.98, implying -65.96% downside; forecasts are model-based projections and not guarantees.

WBA stock: Risks, catalysts and price targets

Primary risks include high leverage, negative EPS, and reimbursement pressure in pharmacy. Catalysts are margin improvement, Boots integration, and specialty pharmacy growth. Use price anchors: conservative target $8.08 (year low), base $11.98 (current), and optimistic $13.25 (year high). Monitor earnings momentum and sector flows in healthcare retail for direction.

Final Thoughts

WBA stock is drawing heavy intraday attention at $11.98 on NASDAQ in the United States because of a volume spike to 452,081,061.00 shares. Fundamentals remain challenged with EPS -7.29, negative free cash flow, and a high debt-equity ratio of 4.04. Technically, the stock sits between its 50-day (11.66) and year high (13.25), offering defined support and resistance for short-term traders. Meyka AI’s proprietary grade is 59.58 (C+, HOLD), and Meyka AI’s forecast model projects a one-year figure of $4.08, implying -65.96% against today’s price; forecasts are model projections and not guarantees. For most-active traders, this is a liquidity-driven name for short-term setups, while long-term investors should weigh balance-sheet repair and operational catalysts before increasing exposure. Meyka AI provides this as part of an AI-powered market analysis platform and recommends following upcoming sector and company news for trade adjustments.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.